Chara Papadaki

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

Cancers

PloS one

Biomedicines

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Eleni D Lagoudaki, Anastasios V Koutsopoulos, Maria Sfakianaki, Chara Papadaki, Georgios C Manikis, Alexandra Voutsina, Maria Trypaki, Eleftheria Tsakalaki, Georgia Fiolitaki, Dora Hatzidaki, Emmanuel Yiachnakis, Dimitra Koumaki, Dimitrios Mavroudis, Maria Tzardi, Efstathios N Stathopoulos, Konstantinos Marias, Vassilis Georgoulias, John Souglakos
LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer. Cancers 16 (10) (2024)
Eleni D Lagoudaki, Anastasios V Koutsopoulos, Maria Sfakianaki, Chara Papadaki, Georgios C Manikis, Alexandra Voutsina, Maria Trypaki, Eleftheria Tsakalaki, Georgia Fiolitaki, Dora Hatzidaki, Emmanuel Yiachnakis, Dimitra Koumaki, Dimitrios Mavroudis, Maria Tzardi, Efstathios N Stathopoulos, Konstantinos Marias, Vassilis Georgoulias, John Souglakos
LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer. Cancers 16 (10) (2024)
Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, Dimitris Mavroudis, Sofia Agelaki
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. PloS one 18 (2) (2023)
Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, Dimitris Mavroudis, Sofia Agelaki
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. PloS one 18 (2) (2023)
Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, Dimitris Mavroudis, Sofia Agelaki
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. PloS one 18 (2) (2023)
Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, Dimitris Mavroudis, Sofia Agelaki
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. PloS one 18 (2) (2023)
Dimitrios Mavroudis, Alexia Monastirioti, Christina A Apostolopoulou, Despoina Aggouraki, Chara Papadaki, Kleita Michaelidou, Maria Vassilakopoulou, Katerina Alexakou, Dimitrios Mavroudis, Sofia Agelaki
TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications. Cancers 14 (4) (2022)
Alexia Monastirioti, Chara Papadaki, Despoina Kalapanida, Konstantinos Rounis, Kleita Michaelidou, Dimitrios Mavroudis, Dimitrios Mavroudis, Sofia Agelaki
Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab. Cancers 14 (19) (2022)
Chara Papadaki, Konstantina Thomopoulou, Alexia Monastirioti, George Koronakis, Dimitrios Mavroudis, Konstantinos Rounis, Lambros Vamvakas, Christoforos Nikolaou, Dimitrios Mavroudis, Sofia Agelaki
MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer. Biomedicines 9 (4) (2021)
Stefanos Kachris, Chara Papadaki, Konstantinos Rounis, Eliza Tsitoura, Chrysanthi Kokkinaki, Christoforos Nikolaou, George Sourvinos, Dimitrios Mavroudis
Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy. Cancer management and research 13 (2021)
Konstantinos Rounis, Dimitrios Makrakis, Chara Papadaki, Alexia Monastirioti, Lambros Vamvakas, Konstantinos Kalbakis, Krystallia Gourlia, Iordanis Xanthopoulos, Ioannis Tsamardinos, Dimitrios Mavroudis, Sofia Agelaki
Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study. PloS one 16 (6) (2021)
Alexia Monastirioti, Chara Papadaki, Konstantinos Rounis, Despoina Kalapanida, Dimitrios Mavroudis, Sofia Agelaki
A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer. Cells 10 (8) (2021)
Maria Sfakianaki, Chara Papadaki, Maria Tzardi, Maria Trypaki, Stavroula Manolakou, Ippokratis Messaritakis, Zenia Saridaki, Elias Athanasakis, Dimitrios Mavroudis, John Tsiaoussis, Nikolaos Gouvas, John Souglakos
PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer. Cancers 12 (8) (2020)
Chara Papadaki, Alexia Monastirioti, Konstantinos Rounis, Dimitrios Makrakis, Konstantinos Kalbakis, Christoforos Nikolaou, Dimitrios Mavroudis, Sofia Agelaki
Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy. Cancers 12 (5) (2020)
Chara Papadaki, Stavroula Manolakou, Eleni Lagoudaki, Spyros Pontikakis, Despo Ierodiakonou, Konstantinos Vogiatzoglou, Ippokratis Messaritakis, Maria Trypaki, Linda Giannikaki, Maria Sfakianaki, Antonia Kalykaki, Dimitrios Mavroudis, Maria Tzardi, John Souglakos
Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study. Cancers 12 (4) (2020)

Chara Papadaki.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chara Papadaki